Behçet's Syndrome: An Update

Saturday, April 13, 2024

4:00 PM – 4:20 PM Central Time

Speaker(s)

Yusuf Yazici, MD

NYU Grossman School of Medicine
La Jolla, CA, United States

Disclosure(s): Amgen: Consultant (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing), Grant/Research Support (Ongoing); Chugai: Consultant (Ongoing); Hemay: Consultant (Ongoing); Soligenix: Consultant (Ongoing)

Disclosure(s):

Yusuf Yazici, MD: Amgen: Consultant (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing), Grant/Research Support (Ongoing); Chugai: Consultant (Ongoing); Hemay: Consultant (Ongoing); Soligenix: Consultant (Ongoing)

The session will review the latest data and understating on diagnosing, treating and monitoring long term outcomes in Behcet syndrome

Learning Objectives:

To accurately diagnose Behcet syndrome and differentiate from common mimics of Behcet
To review treatment options that match the organ and severity of involvement seen in Behcet syndrome
To better understand longterm outcomes in Behcet and how they impact treatment plans for patients